THE NEXT LEADERSHOULDN'T STARTFROM ZERO.
AI-POWERED INSTITUTIONAL MEMORY & LEADERSHIP CONTINUITY
Building an evidence-grounded institutional continuity engine with FastMCP, Switch, and Gemini to reconstruct organizational knowledge, unmask hidden liabilities, and synthesize verifiable handovers.
Pytest Suite • 0 Failures
Switch & OpenCode Integration
Day 1–30 Operational Roadmap
“Direct Contradiction: Doc A specifies Nov 15; Doc B specifies Dec 20 following stress tests.”
Organizations forget.
When key leaders depart, corporate memory fragments across buried files and unrecorded conversations. Successors inherit blind spots, hidden liabilities, and lost rationales.
Buried In Binders
Vital commitments hide in hundred-page contract amendments and chat channels that no one reads until a costly breach occurs.
Vanishing Context
Why an architecture was chosen or a vendor rejected is never formally captured, causing successors to repeat costly missteps.
Invisible Clauses
Auto-renewing six-figure SaaS agreements and vendor contracts trigger unprompted with no assigned successor aware of cancellation windows.
Split Authority
Critical infrastructure like Kubernetes cluster Alpha-9 is left without an assigned owner or steward, creating immediate operational vulnerabilities.
Relay connects the record.
Relay ingests raw institutional archives, verifies cryptographic hashes, and maps people, assets, decisions, and dates into an interconnected topological graph.
Deposit
Ingests PDF, DOCX, TXT archives with local SHA-256 cryptographic verification.
Extract
Identifies people, monetary thresholds, dates, and verbatim character offsets.
Cross-Examine
Detects contradictory dates, superseded roadmaps, and unassigned infrastructure.
Switch Gate
Authenticated humans review, approve, or clarify flagged anomalies before decisions lock.
Continuity
Synthesizes executive briefing, 30-day roadmap, and line-item responsibilities.
Not just what happened. What no longer adds up.
RELAY CROSS-EXAMINES DOCUMENTS TO EXPOSE CONFLICTS, GAPS, AND UNASSIGNED LIABILITIES
Chief Scientific Officer Departure Charter.pdf
“Section 3.2: Dr. Eleanor Vance relinquishes executive sign-off authority for clinical trial budgets effective November 30, 2024. All FDA liaison duties transferred to successor upon board confirmation.”
- Key Personnel: Dr. Eleanor Vance (Departing CSO)
- Effective Departure Date: November 30, 2024
- Regulatory Scope: FDA IND Filings #99201, #99204
- Financial Authorization Threshold: $250,000
All signatories and responsibilities in this record match existing operational records.
Continuity is the deliverable.
Relay turns months of fragmented records into an authoritative Nine-Chapter Handover Dossier with grounded citations, Day-1 roadmaps, and honest insufficient-evidence refusals.
Acme BioSystems Chief Scientific Officer Transition
Context & Decisions
Complete decision log: Phase II trial protocols, patent co-inventor declarations, and active projects.
Obligations & Conflicts
$140,000 lab renewal resolution status, FDA Form 1572 filings, and ratified claims.
Roadmap & Citations
First-month operational blueprint with key stakeholder contacts and cryptographic citation indices.
Leave knowledge, not just documents.
Deposit your institutional records, cross-examine hidden liabilities, and synthesize verifiable handovers that survive any leadership departure.